Who gains from saving nature
Ledger 1 : 33 — For each dollar financing nature-based solutions in 2023, about $33 financed activities harmful to nature. (UNEP)
Cases / Biotech, cloning and de-extinction · United States · 2016–2026

Kraig Biocraft Laboratories: recombinant spider silk claims

Nature's voice · report
No measurement of the harm done to me here is on record.
Did nature suffer? Not measured.
Not on record
  • The record does not name which of my species, waters, soils or forests were harmed.
What the record lacks: 3 none on record · 4 insufficient · 1 not measured · 1 disputed · 1 unclear See the gaps

A Michigan company that breeds genetically modified silkworms announced record cocoon output in 2026 and described it as spider silk. The announcements gave cocoon weight but not the share of spider protein, revenue or customers.

about $53.1 millionReported accumulated loss, fiscal 2024 (reported, not independently verified)
Reported in a reports of the company's SEC Form 10-K; revenue for the year was reported as zero.

Status As of June 2026: the company has announced about 2.5 metric tons of cocoons in one cycle; no spider-silk sales or protein share are on record.

What?
A company announced record output of genetically modified silkworm cocoons and described it as recombinant spider silk, without stating the spider-protein share, revenue or customers. Kraig Biocraft Laboratories
Where?
Company based in Ann Arbor, Michigan, with operations in the United States and Vietnam.
When?
US Army contract announced July 2016; output announcements April and June 2026. Soldier Systems
Who?
Gained
None on record
Lost
None on record
Harmed
None on record
Why?
The company said in 2016 it was on the way to delivering the first commercially viable, mass-produced recombinant spider silk. Soldier Systems
How?
Genetically modified silkworms produce cocoons containing spider protein; the announcements give cocoon weight. GeneOnline
5 of 6 questions answered from the record · open: who

What happened

The record, in order.

Kraig Biocraft Laboratories is an Ann Arbor-based company whose shares trade over the counter. It works with genetically modified silkworms to produce a fibre it calls "Dragon Silk", and operates in the United States and Vietnam.

In July 2016 the company announced its first contract with the US Army: a fully funded base work order of $99,962, with options of up to $1 million. In the same announcement the company said it was on the way to delivering the first commercially viable, mass-produced recombinant spider silk.

Reported figures from the company's annual report for fiscal 2024 (seen only as a reports of the SEC filing) were zero revenue, a net loss of about $3.4 million and an accumulated loss of about $53.1 million, with the auditor warning about the company's ability to continue as a going concern.

In April 2026 the company announced it had produced more than 1.3 metric tons of recombinant spider silk cocoons in a single month. In June 2026 it announced about 2.5 metric tons in a single production cycle. The announcements give the weight of cocoons. They do not state the share of spider protein in the cocoons, and do not report revenue or customers.

The best result reported in the scientific literature cited in the source material is a modified cocoon with up to 35 percent spider protein (MaSp1) by weight. No sale of commercial spider silk by the company is recorded in the sources reviewed.

  1. 2016July: Kraig announces its first US Army contract (base $99,962; options up to $1 million)
  2. 2024Fiscal year: revenue reported as zero; net loss about $3.4 million; accumulated loss about $53.1 million (reported, not independently verified)
  3. 2026April: company announces more than 1.3 metric tons of cocoons in one month. June: about 2.5 metric tons of cocoons in one cycle

What was said

Claims, in the words of those who made them.

Where accounts differ

Each party's account, side by side, with its source. The record does not settle these points; it shows them.

Does announced cocoon tonnage amount to spider-silk output?
Company or project
Kraig Biocraft Laboratories

Announced more than 1.3 metric tons of spider silk cocoons in a month (April 2026) and about 2.5 metric tons of recombinant spider silk in one cycle (June 2026).

Kraig Biocraft Laboratories
Researchers
Scientific literature cited in the source material

The best result reported is up to 35 percent spider protein (MaSp1) by weight in a modified cocoon (Frontiers 2022, citing Xu et al. 2018).

Company or project
Kraig Biocraft Laboratories

No statement on the spider-protein share, revenue or customers appears in the announcements reviewed.

Kraig Biocraft Laboratories

How it looked

What was shown, beside what was recorded.

Shown

  • A contract with the US Army, described as putting the company on the way to delivering the first commercially viable, mass-produced recombinant spider silk (July 2016).
    Kraig Biocraft Laboratories announcement, as reported by Soldier Systems · Soldier Systems
  • More than 1.3 metric tons of spider silk cocoons in a single month, described as a fivefold increase over the previous high (April 2026).
    Kraig Biocraft Laboratories press release, via BioSpace · Kraig Biocraft Laboratories
  • Record of about 2.5 metric tons of recombinant spider silk in one production cycle (June 2026).
    Kraig Biocraft Laboratories, as reported by GeneOnline · GeneOnline

Recorded

  • The April 2026 release states cocoon weight; it gives no spider-protein share and no revenue.
  • The June 2026 figure is a company statement of about 2.5 metric tons of cocoons.
  • Fiscal 2024: revenue zero, net loss about $3.4 million, accumulated loss about $53.1 million, going-concern warning from the auditor (as summarised in a search result of the Form 10-K; not independently verified).

Who gained

Money that reached nature, beside money that stayed elsewhere.

Reached nature or the ground

Not published
No figure published.

Gained elsewhere

Not totalled
Currency: USD · Window: 2016–2024. All figures cover the same period. * Estimate built from cited figures.

Responses on record

  • kraig-biocraft (July 2016; April 2026; June 2026): Announced a US Army contract in July 2016, a monthly output of more than 1.3 metric tons of cocoons in April 2026, and about 2.5 metric tons in a single cycle in June 2026. The announcements do not state spider-protein share, revenue or customers. · Kraig Biocraft Laboratories

In court and with insurers

Every proceeding and every insurer decision on record.

Lawsuits and rulings

No court case on record. No court has ruled on this case.

Insurers

No insurer decision on record.

What nature saw

Outcomes measured on the ground, and nature's note.

Nature's report opens this page. Below: further outcomes measured on the ground.

Cocoon output announced
over 1.3 t in a month; about 2.5 t in a cycle
Company announcements, April and June 2026; cocoon weight, not fibre weight
Spider-protein share of cocoon
Not stated
Neither announcement gives it; the best literature result cited is up to 35% by weight
Revenue, fiscal 2024
0
Reported in a summary of the SEC Form 10-K; not independently verified

What we don't know

Undisclosed, unproven, untried: recorded as data.

Nature

  • Not measured Harm to nature: No independent ecological evaluation is on record.

Figures

  • Insufficient Revenue: Fiscal 2024 per reports of Form 10-K; not independently verified.
  • Insufficient Net loss: Fiscal 2024 per reports of Form 10-K; not independently verified.
  • Insufficient Accumulated loss: Per reports of Form 10-K; not independently verified.

Accounts

  • Disputed Does announced cocoon tonnage amount to spider-silk output?
  • None on record Kraig Biocraft Laboratories: No statement on the spider-protein share, revenue or customers appears in the announcements reviewed.

Record

  • None on record The share of spider protein in the cocoons announced in April and June 2026: neither announcement states it.
  • None on record Revenue and customers in 2026: the announcements do not report them.
  • Unclear Whether the 2026 production took place in Vietnam or the United States: not stated in the sources reviewed.
  • Insufficient The fiscal 2024 financial figures (zero revenue, net loss about $3.4 million, accumulated loss about $53.1 million, going-concern warning) were seen only in a reports of the Form 10-K and are reported but not independently verified.

Did the harm stop?

No environmental harm is recorded in the sources reviewed; the matter concerns product claims.

Who paid?

Not established in the sources reviewed; the company reported an accumulated loss of about $53.1 million (not independently verified).

Sources

Voices on record: ✓ Company or project— Government and regulators— Courts✓ Press and investigations— Communities and civil society— Researchers✓ Standard-setters and registries

Standard-setters and registries

  1. Kraig Biocraft Laboratories Form 10-K, fiscal year 2024
    US Securities and Exchange Commission (EDGAR) · 2025

Connected cases

Related matters, and cases linked to this one through the same organisations, with the role each played in both.

Institutions

SEC
The US Securities and Exchange Commission, which regulates securities markets and what companies tell investors.